Literature DB >> 12051119

Contribution of pharmacists to the reporting of adverse drug reactions.

A C van Grootheest1, E P van Puijenbroek, L T W de Jong-van den Berg.   

Abstract

PURPOSE: The aim of the study is to get a better view about the possible contribution of pharmacists' reports to the quantity and the quality of reports and in this way to the quality of a voluntary reporting system of adverse drug reactions.
METHODS: A total of 15,293 reports, sent to the Netherlands Pharmacovigilance Foundation Lareb between 1995 and 2000 were analysed for the characteristics of pharmacists' reports and the differences with reports from physicians i.e. dispersion of adverse drug reactions in relation to the different System and Organ Classes, the seriousness of the reports according to the CIOMS criteria and the documentation grade of the reports. A total of 200 reports were selected at random and their quality assessed.
RESULTS: Pharmacists are responsible for 40% of the reports sent in to Lareb during this period. Their reports more frequently concern adverse effects in relation to skin and the eyes. Adverse drug reactions reported by pharmacists tend to be less severe than those reported by physicians and pharmacists' reports tend to be of a lower documentation grade than those of physicians. Also, the quality of the clinical information is higher in physicians' reports.
CONCLUSIONS: The contribution of pharmacists to the voluntary reporting system in the Netherlands is of great importance, both for the number and quality of the reports.

Mesh:

Year:  2002        PMID: 12051119     DOI: 10.1002/pds.702

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  21 in total

1.  Labelling and 'Dear Doctor' letters: are they noncommittal?

Authors:  A C Kees van Grootheest; I Ralph Edwards
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Do pharmacists' reports of adverse drug reactions reflect patients' concerns?

Authors:  Kees van Grootheest; Eugène P van Puijenbroek; Lolkje T W de Jong-van den Berg
Journal:  Pharm World Sci       Date:  2004-06

3.  Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal.

Authors:  Maria T Herdeiro; Adolfo Figueiras; Jorge Polónia; J J Gestal-Otero
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.

Authors:  Marta Irujo; Guadalupe Beitia; Maira Bes-Rastrollo; Adolfo Figueiras; Sonia Hernández-Díaz; Berta Lasheras
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  Knowledge, practices and attitudes towards adverse drug reaction reporting by private practitioners from klang valley in malaysia.

Authors:  Renu Agarwal; Aqil Mohammad Daher; Nafeeza Mohd Ismail
Journal:  Malays J Med Sci       Date:  2013-03

6.  Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal.

Authors:  Maria T Herdeiro; Jorge Polónia; Juan J Gestal-Otero; Adolfo Figueiras
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

7.  Pharmacy students' knowledge and perceptions about pharmacovigilance in Malaysian public universities.

Authors:  Ramadan Mohamed Elkalmi; Mohamed Azmi Hassali; Mohamed Izham M Ibrahim; Riyanto T Widodo; Qais M A Efan; Muhammad Abdul Hadi
Journal:  Am J Pharm Educ       Date:  2011-06-10       Impact factor: 2.047

8.  A pharmacovigilance study on patients of bronchial asthma in a teaching hospital.

Authors:  A N Jamali; M Aqil; M S Alam; K K Pillai; P Kapur
Journal:  J Pharm Bioallied Sci       Date:  2010-10

9.  Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria.

Authors:  Kazeem A Oshikoya; Jacob O Awobusuyi
Journal:  BMC Clin Pharmacol       Date:  2009-08-11

10.  Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine.

Authors:  Manuela Tabali; Elke Jeschke; Angelina Bockelbrink; Claudia M Witt; Stefan N Willich; Thomas Ostermann; Harald Matthes
Journal:  BMC Public Health       Date:  2009-07-31       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.